Patents Assigned to The Ohio State University Research
  • Publication number: 20090048265
    Abstract: Antitumor compounds based on the ?1-adrenoceptor antagonist, doxazosin, as well as compositions and methods of use. The disclosed compounds induce apoptosis in cancer cells.
    Type: Application
    Filed: June 17, 2005
    Publication date: February 19, 2009
    Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Ching-Shih Chen, Yeng-Jeng Shaw
  • Patent number: 7491417
    Abstract: Methods for reducing external and internal contamination of shell eggs by utilizing gaseous ozone applied under mild pressure, alone or in combination with UV radiation for external contaminants and gaseous ozone under mild pressure, a mix of carbon dioxide and ozone, heat, vacuum, or combinations thereof for internal contaminants.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: February 17, 2009
    Assignee: The Ohio State University Research Foundation
    Inventors: Ahmed E. Yousef, Luis A. Rodriguez-Romo
  • Patent number: 7485600
    Abstract: Methods and processes for preparing supported metal catalysts are provided, where the supported metal catalysts can be used for the bulk synthesis of carbon nanotubes. The salts of the metal and the support are selected such that they are soluble in the same solvent. The catalyst can be prepared from the liquid phase through joint precipitation of the metal and the support material. The methods can be used to increase the metal load on the support. Use of the catalysts increases the yield of the carbon nanotubes.
    Type: Grant
    Filed: November 17, 2004
    Date of Patent: February 3, 2009
    Assignees: Honda Motor Co., Ltd., The Ohio State University Research Foundation
    Inventors: Avetik Harutyunyan, Toshio Tokune, Elena Mora Fernandez
  • Publication number: 20090020748
    Abstract: Some disclosed interband tunneling diodes comprise a plurality of substantially coherently strained layers including layers selected from a group consisting of silicon, germanium, and alloys of silicon and germanium, wherein at least one of said substantially coherently strained layers is tensile strained. Some disclosed resonant interband tunneling diodes comprise a plurality of substantially coherently strained layers including layers selected from a group consisting of silicon, germanium, and alloys of silicon and germanium, wherein at least one of said substantially coherently strained layers defines a barrier to non-resonant tunnel current. Some disclosed interband tunneling diodes comprise a plurality of substantially coherently strained layers, wherein at least one of said substantially coherently strained layers is tensile strained.
    Type: Application
    Filed: July 17, 2008
    Publication date: January 22, 2009
    Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Niu JIN, Paul R. Berger, Phillip E. Thompson
  • Publication number: 20090010956
    Abstract: The novel omp-1 gene cluster encoding twenty one Ehrlichia ewingii (EE) proteins was isolated and sequenced completely. This invention relates to isolated E. ewingii (EE) polypeptides, isolated polynucleotides encoding EE polypeptides, probes, primers, isolated antibodies and methods of their production, immunogenic compositions and vaccines, as well as methods of using the EE polypeptides, antibodies, probes, and primers for the purpose of diagnosis, therapy and production of vaccines against E. ewingii.
    Type: Application
    Filed: May 5, 2008
    Publication date: January 8, 2009
    Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
    Inventor: Yasuko Rikihisa
  • Publication number: 20090011407
    Abstract: An image data correction apparatus has a motion information acquisition section, a correction section, and a composition section. The motion information acquisition section acquires motion information indicating spatial distribution of the magnitude of motion, in actual space, of a to-be-imaged portion of a subject. Based on the motion information, the correction section performs correction, which is different from correction in a second region, in a first region of image data collected by a scan by magnetic resonance imaging. The composition section composes individual image data of the first region and the second region that are corrected by the correction section.
    Type: Application
    Filed: November 22, 2004
    Publication date: January 8, 2009
    Applicant: The Ohio State University Research Foundation
    Inventors: Yang Liu, Qunmin Zhou, Pan Zheng, Kottil Rammohan, Shili Lin
  • Publication number: 20090004182
    Abstract: The disclosure relates to methods to prevent, treat, or slow the progression viral-associated lymphoproliferative disorders, EBV-associated lymphoproliferative disorders, and post-transplant lymphoproliferative disorders. In the methods, a TGF-? antagonist, e.g., an anti-TGF-? antibody is administered to a subject. Methods for treating viral-associated lymphoproliferative disorders and for enhancing T-cell responsiveness to a viral-associated lymphoproliferative disorder by administering a TGF-? antagonist are also described.
    Type: Application
    Filed: October 12, 2005
    Publication date: January 1, 2009
    Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Robert A. Baiocchi, Michael A. Caligiuri, Anne M. Van Buskirk
  • Publication number: 20080299167
    Abstract: Vascular endothelial growth factor alternative splice variants and methods of their use are provided.
    Type: Application
    Filed: January 27, 2005
    Publication date: December 4, 2008
    Applicant: The Ohio State University Research Foundation Office of Technology Licensing
    Inventors: Fredika Robertson, John Bauer
  • Publication number: 20080300291
    Abstract: Compounds and methods for treating cancer and inducing apoptosis in unwanted rapidly proliferating cells. The compounds are shown in formula I: wherein X is hydroxyl or amino; Y is carboxyl or sulfonyl; R1, R2, R3, and R4 can be the same or different and are selected from hydrogen, halogen, methoxy, trifluoromethyl, hydroxyl and combinations thereof, R5, R6, and R7 may be the same or different and are selected from hydrogen, chloro, bromo, nitro, phenyl, amino, methoxy, and combinations thereof, and derivatives or metabolites thereof.
    Type: Application
    Filed: May 9, 2008
    Publication date: December 4, 2008
    Applicant: The Ohio State University Research Foundation
    Inventors: Ching-Shih Chen, Dasheng Wang, Jing-Ru Weng
  • Patent number: 7455995
    Abstract: Overexpression of the gene, BAALC, in biological samples from a patient is prognostic for tumor aggressiveness and unfavorable patient outcome. The present invention provides polynucleotide primers and probes for assaying for overexpression of BAALC transcripts. Kits containing the primers and probes are also provided. Also provided are antibodies for assaying for overexpression of BAALC proteins as well as peptide immunogens for producing the anti-BAALC antibodies. The present invention also provides methods for characterizing acute myelogenous leukemia, chronic myelogenous leukemia and prostate cancer in a patient, base on detection of BAALC overexpression.
    Type: Grant
    Filed: November 12, 2002
    Date of Patent: November 25, 2008
    Assignee: The Ohio State University Research Foundation
    Inventors: Stephan Markus Tanner, Albert de la Chapelle
  • Publication number: 20080274457
    Abstract: Methods of identifying malignant thyroid tissue comprising testing a thyroid tissue sample for the expression of at least two genes chosen from CCND2, PCSK2, and PLAB. Kits for use in the disclosed methods are also provided.
    Type: Application
    Filed: February 15, 2007
    Publication date: November 6, 2008
    Applicant: The Ohio State University Research Foundation
    Inventors: Charis Eng, Frank Weber
  • Publication number: 20080269309
    Abstract: Use of a new class of phosphoinositide-dependent kinase-1 (PDK-1) inhibitors of formula I for inducing apoptosis in unwanted rapidly proliferating cells, for treating, inhibiting, or delaying the onset of cancer, and for preventing restenosis in a subject that has undergone an angioplasty or stent: wherein X is selected from the group consisting of alkyl and haloalkyl; Ar is an aryl radical selected from the group consisting of phenyl, biphenyl, naphthyl, anthryl, phenanthryl, and fluorenyl; and wherein Ar is optionally substituted with one or more radicals selected from the group consisting of halo, C1-C4 alkyl, C1-C4 haloalkyl, azido, C1-C4 azidoalkyl, aryl, akylaryl, haloaryl, haloalkylaryl, and combinations thereof; and R is selected from the group consisting of nitrile, acetonitrile, ethylnitrile, propylnitrile, carboxamide, amidine, tetrazole, oxime, hydrazone, acetamidine, aminoacetamide, guanidine, and urea.
    Type: Application
    Filed: May 12, 2008
    Publication date: October 30, 2008
    Applicant: The Ohio State University Research Foundation
    Inventor: Ching-Shih Chen
  • Patent number: 7442509
    Abstract: The invention pertains to methods for detecting the presence or absence of a mutation associated with hypertrophic cardiomyopathy in cats, particularly domesticated cats, and more particularly Maine Coon cats. The methods include detecting the presence or absence of a mutation in the feline MYBPC gene, and identifying feline subjects that have or are at risk of developing hypertrophic cardiomyopathy.
    Type: Grant
    Filed: June 1, 2006
    Date of Patent: October 28, 2008
    Assignees: The Ohio State University Research Foundation, University of California, Davis
    Inventors: Kathryn Meurs, Mark Kittleson
  • Publication number: 20080255213
    Abstract: Substituted thiazolidinone carboxylic acid amides and substituted thiazolidine carboxylic acid amides having a structure where the various substituent groups are as defined in the specification. Methods of making these compounds, pharmaceutical compositions containing the compounds, and their use, particularly for treating or preventing cancer, are also disclosed.
    Type: Application
    Filed: April 14, 2008
    Publication date: October 16, 2008
    Applicants: University of Tennessee Research Foundation, Ohio State University Research Foundation
    Inventors: Duane D. Miller, James T. Dalton, Wei Li, Lu Yan
  • Patent number: 7437343
    Abstract: An architecture is disclosed for assistance with exploration of design and other decision spaces and for making decisions. These decision spaces may be very large. The architecture consists of three main components: A Seeker acquires candidates by generating or retrieving them, along with their scores according to one or more criteria. A Filter locates a relatively small number of promising candidates that are retained for further analysis. Various filters may be used to locate the promising candidates. A Viewer allows a user to examine trade-off diagrams, and other linked displays, that present the filtered candidates for evaluation, analysis, further exploration, and narrowing the choice set. The computational load of the Seeker may be distributed among a large number of clients in a client-server computing environment.
    Type: Grant
    Filed: October 26, 2006
    Date of Patent: October 14, 2008
    Assignee: The Ohio State University Research Foundation
    Inventors: John R. Josephson, Balakrishnan Chandrasekaran, Mark Carroll, Naresh Sundaram Iyer
  • Patent number: 7435476
    Abstract: The present teachings are directed toward compositions of supercapacitor electrode materials containing a functionalized carbon nanotube-containing material substantially free of binder material and methods for preparing the functionalized carbon nanotube-containing material.
    Type: Grant
    Filed: October 13, 2005
    Date of Patent: October 14, 2008
    Assignees: Honda Motor Co., Ltd., Ohio State University Research Foundation, The
    Inventors: Sriram Viswanathan, Toshio Tokune
  • Patent number: 7435873
    Abstract: The invention provides soybean plants having a novel determinant, Rps8, for resistance to Phytophthora sojae. The invention also provides methods for identifying germplasms that are either heterozygous or homozygous for Rps8 using marker assisted selection. Genetic markers with known chromosomal location that are associated with the Rps8 gene are used to confirm Rps8-derived Phytophthora sojae resistance in germplasms. Marker assisted selection also used when introgressing Rps8-derived soybean Phytophthora sojae resistance into non-resistant soybean germplasm or less resistant soybean germplasms.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: October 14, 2008
    Assignee: The Ohio State University Research Foundation
    Inventors: Steven St. Martin, Anne Dorrance, Kara Burnham, Ron Fioritto, David Francis, Stuart G. Gordon
  • Publication number: 20080249085
    Abstract: Ansamycin analogs, including maytansinoid analogs, and their use in treating cell proliferative diseases and conditions, and in particular, for use as antitumor agents.
    Type: Application
    Filed: April 4, 2005
    Publication date: October 9, 2008
    Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: John M. Cassady, Heinz G. Floss
  • Publication number: 20080248575
    Abstract: Delivery of drugs or genes to individual cells is achieved on a nanoscale using electroporation techniques. In one method, a flow-through bioreactor having an inlet and an outlet connected by a flow chamber and a nanoporous membrane positioned in the flow chamber is used. Cells to be electroporated are flowed from the inlet to the outlet, a quantum of molecules of the at least one drug or gene in a fluid medium in the flow chamber. An electrical field applied in the flow chamber provides momentum to the molecules in the nanopores, resulting in delivery of the molecules into the plurality of cells.
    Type: Application
    Filed: October 20, 2006
    Publication date: October 9, 2008
    Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: L. James Lee, Shengnian Wang, Yubing Xie, Changchun Zeng, Chee Guan Koh, Zhengzheng Fei
  • Publication number: 20080235829
    Abstract: Methods for altering levels in plants of one or more phenolic compounds that are intermediates or final products of the plant phenylpropanoid pathway are provided. One method comprises transforming a plant cell with an expression construct comprising a nucleic acid which encodes a transactivator protein comprising the myb domain of the maize “ZmMyb-IF35” protein and an activation domain. Another method comprises transforming a plant cell with an expression construct comprising a transgene which encodes an antisense ZmMyb-IF35 RNA. The present invention also relates to expression constructs and vectors used in the present methods, transformed plant cells and transgenic plants prepared according to the present methods, and the seeds of such transgenic plants.
    Type: Application
    Filed: December 22, 2006
    Publication date: September 25, 2008
    Applicant: The Ohio State University Research Foundation
    Inventors: Erich Grotewold, Anusha P. Dias, Edward L. Braun